Hennion & Walsh Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,305
| Closed | -$543K | – | 820 |
|
|
2023
Q1 | $543K | Sell |
9,305
-319
| -3% | -$18.6K | 0.03% | 492 |
|
|
2022
Q4 | $491K | Sell |
9,624
-8,804
| -48% | -$449K | 0.03% | 507 |
|
|
2022
Q3 | $1.51M | Sell |
18,428
-683
| -4% | -$55.9K | 0.1% | 244 |
|
|
2022
Q2 | $1.29M | Sell |
19,111
-6,611
| -26% | -$447K | 0.08% | 261 |
|
|
2022
Q1 | $2.84M | Sell |
25,722
-524
| -2% | -$57.9K | 0.15% | 180 |
|
|
2021
Q4 | $2.53M | Sell |
26,246
-919
| -3% | -$88.6K | 0.12% | 208 |
|
|
2021
Q3 | $2.37M | Buy |
27,165
+2,112
| +8% | +$184K | 0.12% | 220 |
|
|
2021
Q2 | $3.88M | Buy |
25,053
+7,255
| +41% | +$1.12M | 0.21% | 125 |
|
|
2021
Q1 | $2.81M | Buy |
+17,798
| New | +$2.81M | 0.17% | 172 |
|